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US Federal Trade Commission, Washington DC.
The FTC’s PAE Study: Doing
More Harm Than Good
Recently, the Federal Trade Commission
(FTC) released a report of its study of
patent assertion entities (PAEs). The report
was long anticipated and could have gone
a long way to shining some light on patent
licensing firms – who they are, how they
operate, and so on. A¸er all, patent
licensing firms are misunderstood,
partially because so much of their activity
is not visible to the public. In theory,
because the FTC has the power to obtain
this invisible information, the study could have provided the data and insight needed to
better understand these firms and improve the policy dialogue surround their behaviors. This
PAE study had the potential to do a world of good…but unfortunately, the resulting report is
likely to do more harm than good.
To be fully transparent, I was unconvinced from the outset that the FTC’s PAE study would
promote any real insight into patent licensing firms because the study was poorly designed.
Specifically, I argued that 1) the subjects of the FTC PAE study did not represent a realistic
picture of the patent licensing landscape and 2) the questions asked by the FTC were not
designed to develop an understanding of these firms and how they operate. I concluded that
the FTC’s study had the potential to cause more harm than good, because “inaccurate and
incomplete data will go far to bolster the inapt theories that are currently holding the day for
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those who wish to hinder, if not destroy, patent licensing firms.” Now that the report has been
released, my fears have been realized.
To put my remaining remarks in context, here is a quick summary of the relevant portions of
the FTC report. The FTC identified two types of business models in its study of PAES. Portfolio
PAEs are those firms that license large (and valuable) portfolios of patents, that generally
negotiate licenses without filing lawsuits, and that generate significant revenue. Litigation
PAEs are firms that instead have small portfolios, that typically sue first then settle, and that
generally settle for small amounts of money (less than $300K). Litigation PAEs, according to
the report, engage in what could be considered nuisance litigation. Because of the extent of
nuisance litigation, the FTC provided four policy recommendations:
Develop rules and case management practices to address discovery burden and cost
asymmetries in PAE litigation
Amend rules to reach a broader range of non-party interested entities or persons
Establish procedures encouraging courts to stay a PAE’s infringement action against
customers or end-users, where the PAE has also sued the manufacturer of the accused
product under the same theory of infringement
Ensure that patent infringement complaints provide su·icient notice to accused
infringers.
Putting aside my concerns with the study’s design mentioned above, I think the FTC report
itself is terribly flawed. Here are four primary reasons why the FTC’s report is likely to do more
harm than good:
The FTC failed to capitalize on the one shining point of light
from the PAE study
The FTC report should be applauded for its recognition that not all patent licensing firms are
the same – this is an argument that academics (including myself) have been making for years.
The FTC’s definition of PAEs had already identified NPEs as something separate – PAEs acquire
patents to monetize them, while NPEs develop and patent technology and then monetize
them. Now, in the report, the FTC admits that even PAEs are not a homogenous group.
Specifically, the FTC categorized PAEs as either portfolio PAEs or litigation PAEs. Portfolio PAEs
are those with large portfolios, they tend to license before they sue, they make lots of
money…in short, the implication is that these are “good” PAEs. Litigation PAEs, on the other
hand, have smaller portfolios, they like to sue and then settle, they make much less money,
and generally they engage in “nuisance” lawsuits. Because the FTC makes policy
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recommendations to address this “nuisance” litigation, clearly the FTC has classified litigation
PAEs as “bad.”
So while I congratulate the FTC for finally appreciating that PAEs are not one big homogenous
group, there are two problems that flow from this appreciation.
First, the categories themselves are problematic. The division between the two categories is
too coarse a filter to be at all meaningful – patent licensing firms are simply too diverse and
too complex to divvy into two overly simplistic classifications. Further, by virtue of how the
PAEs were selected, the study was designed to be focused on the litigation, or “bad,” PAEs.
There is no real understanding of the patent licensing landscape to be gained from these
artificially created categories based on poorly selected study PAEs. In fact, continuing to
essentially classify PAEs as either “good” portfolio or “bad” litigation PAEs will simply
continue (and likely promote) the unsupported narrative that existed prior to the study.
Second, and this should be made clear to those PAEs who breathed a sigh of relief when they
discovered they may fit into the portolio PAE category…it doesn’t matter. Although the FTC
took a brave step towards advancing the policy dialogue by recognizing the heterogeneity of
patent licensing firms, it then takes a giant leap backwards by promoting policy
recommendations that fail to retain any distinction between PAE types. Although the report
acknowledged that di·erent patent licensing firms may act di·erently, may exist for di·erent
purposes, etc., when the FTC set forth its recommendations, any di·erentiation between
patent licensing firms failed to exist – the legislative and judicial reforms suggested by the
FTC’s report apply to PAEs generally. In my opinion, to say that PAEs di·er from each other, in
at least some respects, but to then propose changes to the law that apply across the board is
more harmful than not acknowledging the diversity of patent licensing firms in the first
instance.
The FTC’s policy recommendations are based on incomplete
facts
Again, putting aside my concerns with the study design, there are at least two big pieces of
evidence that the FTC study is missing in order for its policy recommendations to be
supported by facts.
First, the FTC admits it cannot speak to any e·iciencies created by patent licensing activity,
because the data were just too hard to collect. I’m not terribly convinced by this point – but
assuming that the FTC truly was not capable of collecting and understanding these data, how
in the world can it make policy recommendations with only part of the information
necessary? It could turn out, and people have argued, that patent licensing creates all sorts of
advantages for inventors, innovators, the economy, etc. Yet, without any evidence about the
extent of these benefits of patent licensing activity, with no assessment about how patent
licensing positively a·ects competition, and with no ability to balance these benefits against
the negatives, the FTC made recommendations that could have expansive e·ects on patent
licensing activity.
Second, the FTC claims that at least some of its policy recommendations are designed to
address information asymmetries between PAEs and defendants in patent litigation. In order
to validate the existence of information asymmetries, however, don’t we need to have some
data from the other side…specifically, the defendants? As it stands, the existence of
information asymmetries is largely based on anecdote, not evidence, and the extent to which
these information asymmetries cause quantifiable harms is even less supported. If, as one
would understand from reading the FTC’s report, information asymmetries are one of the
biggest problems with PAE activity, this information could have – should have – been
gathered through this extraordinary opportunity provided by the FTC’s study.
Basing policy recommendations on no evidence, or at best anecdotal evidence, has great
potential to do more harm than good…especially when some of the missing evidence is the
other side of the equation – the benefits a·orded by patent licensing activity.
The FTC’s policy recommendations are not supported by the
facts gathered in the study
In addition to my concern that the facts alleged to support the policy recommendations are
incomplete, there is a larger concern that the facts that actually were gathered by the study
simply do not support the policy recommendations. There is very little connection between
the data gathered by the PAE study and the recommendations made. Perhaps Judge Douglas
Ginsburg, speaking at event put on the by Searle Center on Law, Regulation, and Economic
Growth at Northwestern Pritzker School of Law, said it best: he remarked the report
concludes with “a set of recommendations that is free-floating from the study but worthy of
consideration.”
One example of the disconnect between the study results and the recommendations goes
back to my first point, above. Although the study demonstrated there are di·erent types of
PAEs and they behave in di·erent ways, NONE of the policy recommendations is aimed at one
type or another type of PAE…the recommendations are simply aimed at the broad,
homogenous category of patent licensing behavior. Another example is the recommendation
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to increase disclosure of related entities in patent infringement litigation involving PAEs.
Although the study may have uncovered that some patent licensing firms have a large
number of related entities, and some of these related entities may assert patents and a lot of
them do not, this fact alone – the existence of related entities – does not justify a call for
increased disclosure. The FTC discovered no evidence that a lack of disclosure of related
entities creates any problems for innovation nor does the lack of disclosure, based on the
study, create any real hardships for the defendants in these cases. There are other examples
of this lack of connection between the FTC’s policy recommendations and the results of the
study, but the bottom line is this: regardless of how valid some of these policy
recommendations may be (and I’m not taking any position on the validity of these
recommendations in this piece), to set forth a set of policy recommendations as part of an
extensive study, where the policy recommendations are virtually divorced from anything
learned in the study is not just irresponsible, but likely to do more harm than good.
The FTC’s policy recommendations are based on a poor proxy
for “nuisance” litigation
A lot of the FTC’s report, starting with its categorization of “bad” litigation PAEs, is based on
the assertion that PAEs engage in “nuisance” litigation…and the recommendations are
suggested specifically to achieve a balance between protecting patent rights and “nuisance”
litigation. Accepting the FTC’s proxy for nuisance litigation will result not only in more harm
than good, but will also eviscerate a fundamental right of patent law. The FTC alleges that,
especially for the litigation PAE type, patent licensing firms o¸en engage in litigation that
results in settlements of less than $300K. This number was not plucked from the air by the
FTC; it represents the lower band of costs required to defend a patent suit according to AIPLA
(for the relevant time period of the FTC study). The reasoning is that because the lawsuits
settle for less than it would cost for the defendant to defend itself in court, this must be a
nuisance…implying (or perhaps explicitly stating) that these lawsuits need to be stopped. But
<$300K is a terrible proxy for what suits shouldn’t be brought.
First, there is a substantial di·erence between nuisance and meritless. Nuisance means that
the alleged cost-benefit analysis would lead us to believe that bringing the lawsuit is not the
best use of resources…but that doesn’t mean there is no infringement and it doesn’t mean
the patent is invalid. If we start taking an axe to any case that results in <$300K in damages or
settles for less than that, we seem to be permitting, or even encouraging, de minimis or low
level infringement. But that is not part of the patent system; in fact, the US Court of Appeals
for the Federal Circuit has specifically said that de minimis infringement is still infringement.
Setting an artificial cuto· for what cases are “worth” bringing (and determining whether
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Hey Kristen,
Nice article on this FTC report. Your comment that you’re “not terribly convinced” by the “FTC
admit[ing] it cannot speak to any e·iciencies created by patent licensing activity, because the data
were just too hard to collect” is right on. That data is certainly attainable (for example, from
1. 
patent licensing activity is “good” or “bad” based on this artificial cuto·) seems to be
antithetical to patent law, which provides a right to exclude even a tiny bit of infringing
behavior.
Second, the factors surrounding patent litigation and settlement are extensive and case-by-
case unique…and cannot be understood or explained simply by looking to a bare number,
like $300K. In fact, in an old patent textbook I used to teach from, there was a case that went
to verdict and the patentee was awarded $69 and change. You read that right, just $69. The
case was NOT included in the textbook as an example of cases that should not be brought; in
fact, I loved teaching that case to provide the insight that there are a lot more things going on
in patent cases than you can gather from the damages award…and understanding what is
going on is critical. By looking at settlement numbers and concluding, ah, that must be a
nuisance case, is a vast oversimplification of patent law. Patent law, and specifically patent
licensing behavior, is far too important and complex and fact-specific to base
recommendations on this type of oversimplification. And while it’s hard to understand what is
going on behind the scenes that is precisely what the FTC study was supposed to do for us.
Instead of seizing the opportunity to survey the patent licensing landscape and shed light on
behavior that otherwise is invisible to the public, the FTC squandered the chance and instead
developed two arbitrary categories of PAEs, determined that one of these categories was not
good, and developed a set of policy recommendations because of “nuisance” litigation. By
making recommendations without gathering or using the very facts that were supposed to be
the public benefit of this PAE study, the FTC’s report is undoubtedly going to do more harm
than good.
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